Skip to content
Search

Latest Stories

Trailer of Pawan Kalyan starrer Vakeel Saab to be out on 29th March, reveals Boney Kapoor

Trailer of Pawan Kalyan starrer Vakeel Saab to be out on 29th March, reveals Boney Kapoor

By Murtuza Iqbal

Vakeel Saab starring Pawan Kalyan in the lead role is one of the most awaited Telugu films of the year. The movie is directed by Venu Sriram and produced by Dil Raju and Boney Kapoor.


While a couple of songs of the film have already been released, the fans of Pawan Kalyan have been waiting for the trailer of the movie, and finally, the wait will come to an end on 29th March 2021.

Boney Kapoor took to Twitter to inform everyone the trailer of Vakeel Saab will be out on 29th March. He tweeted, “The Power Fire In Black-Blazer gets mightier! Witness it with #VakeelSaabTrailer on March 2️⃣9️⃣th @PawanKalyan #SriramVenu @shrutihaasan @SVC_official @i_nivethathomas @MusicThaman @yoursanjali @AnanyaNagalla @bayviewprojoffl @BoneyKapoor @adityamusic #VakeelSaabOnApril9th.”

Vakeel Saab is slated to release on 9th April 2021 and it also stars Anjali, Nivetha Thomas, Ananya Nagalla, Prakash Raj, and Shruti Haasan. The film is a remake of the Hindi film PINK which featured Amitabh Bachchan, Taapsee Pannu, Kirti Kulhari, and Andrea Tariang in the lead roles.

This is the second remake of PINK, earlier Boney Kapoor had also produced the Tamil remake of the film titled Nerkonda Paarvai. It featured Ajith Kumar in the lead role, and it was a blockbuster at the box office.

Fans of Pawan Kalyan have been eagerly waiting for Vakeel Saab as they will get to see their favourite star on the big screen after a gap of three years. The actor’s last release was Agnyaathavaasi (2018).

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less